| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 118,677 | 119,267 | 128,011 | | Cost of Revenue | 85,580 | 84,318 | 95,134 | | | Gross Profit | 33,097 | 34,949 | 32,877 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 27,903 | 29,489 | 24,424 | | Non Recurring | 934 | 552 | 99,285 | | Others | 14,984 | 14,482 | 13,981 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (10,724) | (9,574) | (104,813) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 154 | 285 | 2,457 | | Earnings Before Interest And Taxes | (10,570) | (9,289) | (102,356) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (10,570) | (9,289) | (102,356) | | Income Tax Expense | (3,366) | (2,841) | (2,141) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,204) | (6,448) | (100,215) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 2,327 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,204) | (6,448) | (97,888) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,204) | ($6,448) | ($97,888) |
|
1.52% Nasdaq 
Income Statement
